Regulatory Compliance Decision

6120.1 - Regulatory Compliance Decision (Rev. 230; Issued: 07-11-25; Effective: 07-11-25; Implementation: 07-11-25) After all necessary information has been collected and the surveyor determines whether any identified laboratory testing-related problems do (or could) negatively impact patient test outcomes, and, if so, whether such problems are due to non-compliance with CLIA, the surveyor will need to determine whether CLIA-related non-compliance driven issues constitute a condition-level deficiency. Review the findings and decide if additional information and/or documentation are necessary to substantiate and document a standard- or condition-level deficient practice. The number of deficiencies generally does not correlate to whether a laboratory should be found out of compliance with a standard or condition. Standard-level deficiencies require: (1) the documentation of the nature and extent of the deficiencies, if any, with respect to a particular function, i.e., the creation of a list of the deficient practices; and (2) the surveyor to assess the need for improvement in relation to the prescribed conditions, i.e., review standard-level deficiencies to determine condition-level non-compliance. With the exception of the four mandatory condition-level citations discussed in subsection VII.D. below, consider a condition out of compliance as a result of one or more deficiencies if, in your judgment, the deficiency(ies) constitutes a significant or a serious problem that adversely affects patient test results/patient care, or has the potential for adversely affecting patient test results/patient care. Determining Immediate Jeopardy Immediate Jeopardy (IJ) represents a situation in which laboratory noncompliance has placed the health and safety of recipients in its care at risk for serious injury, serious harm, serious impairment or death. These situations must be accurately identified by surveyors, thoroughly investigated, and resolved by the entity as quickly as possible. In addition, noncompliance cited at IJ is the most serious deficiency type, and carries the most serious sanctions for laboratories. An immediate jeopardy situation is one that is clearly identifiable due to the severity of its harm or likelihood for serious harm and the immediate need for it to be corrected to avoid further or future serious harm. Immediate jeopardy is defined in 42 CFR §493.2 as “a situation in which immediate corrective action is necessary because the laboratory’s noncompliance with one or more condition-level requirements has already caused, is causing, or is likely to cause, at any time, serious injury or harm, or death, to individuals served by the laboratory or to the health or safety of the general public”. The regulatory definitions form the basis for identifying three key components that are essential for surveyors to use in determining the presence of IJ. These components include: • Noncompliance: An entity has failed to meet one or more federal health, safety, and/or quality regulations; AND • Serious Adverse Outcome or Likely Serious Adverse Outcome: As a result of the identified noncompliance, serious injury, serious harm, serious impairment or death has occurred, is occurring, or is likely to occur to one or more identified recipients at risk; AND • Need for Immediate Action: The noncompliance creates a need for immediate corrective action by the provider/supplier to prevent serious injury, serious harm, serious impairment or death from occurring or recurring. (See 42 CFR §493.1812 providing the enforcement actions to be taken when deficiencies pose immediate jeopardy.) Refer to Figure 4-1 for guidance in determining whether to issue condition (and/or standard) citations and what enforcement actions to pursue. The number of deficiencies does not necessarily relate to whether or not a condition is found out of compliance, but rather the impact or potential impact the deficiency(ies) has (have) on the quality of laboratory services and the results reported. Figure 4-1, steps four through six, presents the decision steps for citing deficiencies in relation to patient outcome. In step four, the surveyor cites applicable CLIA conditions, Mandatory CLIA Citations and/or supporting CLIA standards that are not met by the laboratory. Upon citing condition(s), step five is to determine whether the situation already caused, is causing, or likely to cause serious injury, harm or death. If yes, step 6 is to proceed with citing Immediate Jeopardy (IJ) along with the condition-level non- compliance. If the surveyor concludes no IJ is present, proceed with citing condition(s) as identified under step four. When determining if the condition-level noncompliance reaches the level of immediate jeopardy. The surveyors should ask themselves: Do the deficient practices result in inaccurate or the high probability of inaccurate, unreliable, or untimely test results? • Is the situation one in which immediate corrective action is necessary because the laboratory’s noncompliance has already caused or is likely to cause serious injury, harm, or death to individuals served by the laboratory? • Does the laboratory’s continued activity(ies) constitute a significant hazard to individuals served by the laboratory or to the public health or safety of the general public? • Do the deficiencies warrant immediate limitation or suspension of the laboratory’s CLIA certificate? • Is there information or data not available at the time of the survey, or within a reasonable time frame, that must be provided by the laboratory in order to determine if the deficient practice has already caused, is causing, or is likely to cause, at any time, serious injury or harm, or death? In summary, the steps for regulatory considerations include: 1. Are CLIA regulatory deficiencies identified? 2. Does the deficiency(ies) constitute(s) condition-level non-compliance? - Do the deficiencies prevent certification? 3. Does the condition-level non-compliance pose an immediate jeopardy to patient health and safety? - Is there an option for other enforcement remedies? Refer to Revisions to Appendix Q, Guidance on Immediate Jeopardy, for further information.